Overview

Clinical Study of NPC-12Y Gel in Patients With Skin Lesions Associated With TSC

Status:
Recruiting
Trial end date:
2024-09-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the efficacy and safety of NPC-12Y gel compared with placebo for skin lesions associated with tuberous sclerosis.
Phase:
Phase 3
Details
Lead Sponsor:
Nobelpharma